Form 4: Bioventus Inc. Director Pat Beyer Reports Stock Vesting
SEC Form 4 Filing
Director Pat Beyer reports the vesting of 965 Class A Common Stock shares at Bioventus Inc.
Summary
- On June 16, 2024, Director Pat Beyer reported a transaction involving Bioventus Inc. (BVS) Class A Common Stock.
- 965 shares vested at a price of $0.
- Following the transaction, Beyer directly owns 49,943 shares of Class A Common Stock.
- The transaction involved the vesting of 965 Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Class A common stock.
Sentiment
Score: 5
Explanation: This is a neutral report on stock vesting, a normal part of executive compensation. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock-based awards, common in publicly traded companies.
Stakeholder Impact
- The vesting of shares may have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/16/2024 | Date of earliest transaction and RSU vesting |
| 06/18/2024 | Date of signature for the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.